News & Updates

Show Multimedia Only

Diet, exercise reduce serum lipids linked to insulin resistance

12 Dec 2024

Lifestyle interventions, including diet and exercise, can help lower serum sphingolipid species associated with insulin resistance, suggest the results of a recent study.

Diet, exercise reduce serum lipids linked to insulin resistance

12 Dec 2024

Celebrex and recent updates

12 Dec 2024

Celecoxib (Celebrex®) has been a cornerstone in managing various inflammatory conditions, such as osteoarthritis, rheumatoid arthritis, and acute pain, for over two decades. As a selective COX-2 inhibitor, it offers anti-inflammatory and analgesic effects while minimizing the gastrointestinal risks associated with non-selective NSAIDs. Recent research and clinical guidelines have brought new insights into its use, efficacy, and safety profile, prompting a re-evaluation of its place in therapy.

Celebrex and recent updates

12 Dec 2024

GLP1-RAs hold potential for asthma control

12 Dec 2024 by

Data presented at APSR 2024 demonstrate the ability of glucagon-like peptide 1 receptor agonists (GLP1-RAs) to benefit obese individuals with asthma.

GLP1-RAs hold potential for asthma control

12 Dec 2024

Indoor air purifiers good for children’s pulmonary health

12 Dec 2024

Prolonged air purification in indoor environments helps alleviate airway inflammation in children, a study has shown.

Indoor air purifiers good for children’s pulmonary health

12 Dec 2024

Odevixibat shows rapid, sustained benefits in patients with ALGS

12 Dec 2024 by

Treatment with odevixibat led to rapid and sustained improvements in pruritus and serum bile acid (sBA) levels among patients with Alagille syndrome (ALGS), according to the ﬁnal data of the phase III ASSERT-extension (ASSERT-EXT) study presented at The Liver Meeting 2024.

Odevixibat shows rapid, sustained benefits in patients with ALGS

12 Dec 2024

Navigating invasive candidiasis diagnosis and management in non-neutropenic ICU patients

12 Dec 2024

At a recent Pfizer-sponsored webinar, Dr Paula Ramirez Galleymore, an Intensive Care Medicine specialist from La Fe University and Polytechnic Hospital in Valencia, Spain, addressed the pressing issue of invasive candidiasis in the ICU — often an overlooked but frequent intruder in critical care settings. Galleymore discussed key aspects, including the primary risk factors associated with invasive Candida infections, emphasizing the need for early intervention to improve patient outcomes. She also explored antifungal treatment options, focusing on the clinical efficacy and guideline recommendations for echinocandins.

Navigating invasive candidiasis diagnosis and management in non-neutropenic ICU patients

12 Dec 2024

Some patients hesitant to perform self-wound care

11 Dec 2024 by

Some patients are reluctant to manage their own wounds, and this hesitation appears to be influenced by factors such as family support, among others, according to a study from Singapore.

Some patients hesitant to perform self-wound care

11 Dec 2024

Anticoagulants up risk of bleeding after ERCP

11 Dec 2024

Endoscopists may unintentionally play down the risks of antiplatelet-related postendoscopic retrograde cholangiopancreatography (ERCP) bleeding (CSPEB) based on observations of suboptimal holding before higher risk ERCP, reports a study.

Anticoagulants up risk of bleeding after ERCP

11 Dec 2024

Baseline IOP predicts treatment response for SLT, PGA drops

11 Dec 2024 by

Primary treatment with either selective laser trabeculoplasty (SLT) or prostaglandin analog (PGA) drops for ocular hypertension and open-angle glaucoma results in a decrease in intraocular pressure (IOP), and this benefit is greater with higher baseline IOP, a study has shown.

Baseline IOP predicts treatment response for SLT, PGA drops

11 Dec 2024

Metformin improves responses to chemotherapy in nondiabetic breast cancer

11 Dec 2024

Use of metformin in nondiabetic breast cancer patients improves their clinical and pathological response to neoadjuvant AC-T chemotherapy, reveals a recent study.

Metformin improves responses to chemotherapy in nondiabetic breast cancer

11 Dec 2024

News & Updates

Filter by Specialty:

Specialty:

Diet, exercise reduce serum lipids linked to insulin resistance

Diet, exercise reduce serum lipids linked to insulin resistance

Celebrex and recent updates

Celebrex and recent updates

GLP1-RAs hold potential for asthma control

GLP1-RAs hold potential for asthma control

Indoor air purifiers good for children’s pulmonary health

Indoor air purifiers good for children’s pulmonary health

Odevixibat shows rapid, sustained benefits in patients with ALGS

Odevixibat shows rapid, sustained benefits in patients with ALGS

Navigating invasive candidiasis diagnosis and management in non-neutropenic ICU patients

Navigating invasive candidiasis diagnosis and management in non-neutropenic ICU patients

Some patients hesitant to perform self-wound care

Some patients hesitant to perform self-wound care

Anticoagulants up risk of bleeding after ERCP

Anticoagulants up risk of bleeding after ERCP

Baseline IOP predicts treatment response for SLT, PGA drops

Baseline IOP predicts treatment response for SLT, PGA drops

Metformin improves responses to chemotherapy in nondiabetic breast cancer

Metformin improves responses to chemotherapy in nondiabetic breast cancer